Henk‐Jan Drenth

458 total citations
17 papers, 376 citations indexed

About

Henk‐Jan Drenth is a scholar working on Health, Toxicology and Mutagenesis, Pulmonary and Respiratory Medicine and Physiology. According to data from OpenAlex, Henk‐Jan Drenth has authored 17 papers receiving a total of 376 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Health, Toxicology and Mutagenesis, 3 papers in Pulmonary and Respiratory Medicine and 3 papers in Physiology. Recurrent topics in Henk‐Jan Drenth's work include Toxic Organic Pollutants Impact (3 papers), Effects and risks of endocrine disrupting chemicals (2 papers) and Hepatocellular Carcinoma Treatment and Prognosis (2 papers). Henk‐Jan Drenth is often cited by papers focused on Toxic Organic Pollutants Impact (3 papers), Effects and risks of endocrine disrupting chemicals (2 papers) and Hepatocellular Carcinoma Treatment and Prognosis (2 papers). Henk‐Jan Drenth collaborates with scholars based in Netherlands, Germany and United States. Henk‐Jan Drenth's co-authors include Willem Seinen, C.A. Bouwman, Jean Smeets, Bart A. Ploeger, Meindert Danhof, Julian Howell, Dirk Garmann, Martin van den Berg, Raymond Pieters and Stephen Safe and has published in prestigious journals such as Chemosphere, Anesthesiology and Toxicology and Applied Pharmacology.

In The Last Decade

Henk‐Jan Drenth

16 papers receiving 364 citations

Peers

Henk‐Jan Drenth
A.E. Karakaya Türkiye
Hua Xu China
Ali Esat Karakaya Türkiye
U. Plappert Germany
Maggie M. Ramzy Egypt
Myoung Seok Han South Korea
André Viau Canada
Flavio Martı́nez Mexico
Eleftheria Maria Panagiotou Sweden
A.E. Karakaya Türkiye
Henk‐Jan Drenth
Citations per year, relative to Henk‐Jan Drenth Henk‐Jan Drenth (= 1×) peers A.E. Karakaya

Countries citing papers authored by Henk‐Jan Drenth

Since Specialization
Citations

This map shows the geographic impact of Henk‐Jan Drenth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henk‐Jan Drenth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henk‐Jan Drenth more than expected).

Fields of papers citing papers by Henk‐Jan Drenth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Henk‐Jan Drenth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henk‐Jan Drenth. The network helps show where Henk‐Jan Drenth may publish in the future.

Co-authorship network of co-authors of Henk‐Jan Drenth

This figure shows the co-authorship network connecting the top 25 collaborators of Henk‐Jan Drenth. A scholar is included among the top collaborators of Henk‐Jan Drenth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Henk‐Jan Drenth. Henk‐Jan Drenth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
2.
Willmann, Stefan, Katrin Coboeken, Yang Zhang, et al.. (2021). Population pharmacokinetic analysis of rivaroxaban in children and comparison to prospective physiologically‐based pharmacokinetic predictions. CPT Pharmacometrics & Systems Pharmacology. 10(10). 1195–1207. 10 indexed citations
3.
Drenth, Henk‐Jan, et al.. (2020). Population pharmacokinetics of regorafenib in solid tumours: Exposure in clinical practice considering enterohepatic circulation and food intake. British Journal of Clinical Pharmacology. 86(12). 2362–2376. 18 indexed citations
4.
5.
6.
Drenth, Henk‐Jan, et al.. (2018). An Integrated Population Pharmacokinetic Analysis to Characterize Levonorgestrel Pharmacokinetics After Different Administration Routes. The Journal of Clinical Pharmacology. 58(12). 1639–1654. 28 indexed citations
7.
Solms, Alexander, Henk‐Jan Drenth, Jordi Bruix, et al.. (2017). Exposure–response relationship of regorafenib efficacy in patients with hepatocellular carcinoma. European Journal of Pharmaceutical Sciences. 109. S149–S153. 18 indexed citations
8.
Huntjens, Dymphy, et al.. (2016). Population Pharmacokinetic Modeling of Tapentadol Extended Release (ER) in Healthy Subjects and Patients with Moderate or Severe Chronic Pain. Clinical Drug Investigation. 36(3). 213–223. 8 indexed citations
9.
DeJongh, Joost, et al.. (2013). Pharmacokinetics of Recombinant Human Antithrombin in Delivery and Surgery Patients With Hereditary Antithrombin Deficiency. Clinical and Applied Thrombosis/Hemostasis. 20(4). 355–364. 5 indexed citations
10.
Ravenstijn, Paulien, Henk‐Jan Drenth, Michael J. O’Neill, Meindert Danhof, & Elizabeth C. M. de Lange. (2012). Evaluation of blood-brain barrier transport and CNS drug metabolism in diseased and control brain after intravenous L-DOPA in a unilateral rat model of Parkinson's disease. Fluids and Barriers of the CNS. 9(1). 4–4. 24 indexed citations
11.
Howell, Julian, et al.. (2009). Pharmacokinetics of a granisetron transdermal system for the treatment of chemotherapy-induced nausea and vomiting. Journal of Oncology Pharmacy Practice. 15(4). 223–231. 35 indexed citations
12.
Ploeger, Bart A., Jean Smeets, Henk‐Jan Drenth, et al.. (2008). Pharmacokinetic-Pharmacodynamic Model for the Reversal of Neuromuscular Blockade by Sugammadex. Anesthesiology. 110(1). 95–105. 36 indexed citations
13.
14.
Drenth, Henk‐Jan, et al.. (2000). Induction of hepatic cytochrome p450 activities by toxaphene in rat and japanese quail. Environmental Toxicology and Chemistry. 19(11). 2806–2811. 3 indexed citations
15.
Letcher, Robert J., Ineke van Holsteijn, Henk‐Jan Drenth, et al.. (1999). Cytotoxicity and Aromatase (CYP19) Activity Modulation by Organochlorines in Human Placental JEG-3 and JAR Choriocarcinoma Cells. Toxicology and Applied Pharmacology. 160(1). 10–20. 55 indexed citations
16.
Drenth, Henk‐Jan, et al.. (1998). Effects of Some Persistent Halogenated Environmental Contaminants on Aromatase (CYP19) Activity in the Human Choriocarcinoma Cell Line JEG-3. Toxicology and Applied Pharmacology. 148(1). 50–55. 71 indexed citations
17.
Belfroid, A.C., et al.. (1995). Dietary Uptake of Superlipophilic Compounds by Earthworms (Eisenia andrei). Ecotoxicology and Environmental Safety. 31(3). 185–191. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A.E. Karakaya Breakdown of academic impact, for papers by Hua Xu Breakdown of academic impact, for papers by Ali Esat Karakaya Breakdown of academic impact, for papers by U. Plappert Breakdown of academic impact, for papers by Maggie M. Ramzy Breakdown of academic impact, for papers by Myoung Seok Han Breakdown of academic impact, for papers by André Viau Breakdown of academic impact, for papers by Flavio Martı́nez Breakdown of academic impact, for papers by Eleftheria Maria Panagiotou
Rankless by CCL
2026